Oral Paclitaxel Non-Inferior to IV Paclitaxel in HER2-Negative mBC
DESTINY-Breast06: T-DXd Outperforms Chemo in HER2-Low/Ultralow HR+ mBC Across Mutations
INAVO120: Inavolisib Delays Chemotherapy and Boosts OS in HR+/HER2– aBC